AU2003296869A1 - Novel molecule for inducing differentiation of dendritic cells - Google Patents

Novel molecule for inducing differentiation of dendritic cells

Info

Publication number
AU2003296869A1
AU2003296869A1 AU2003296869A AU2003296869A AU2003296869A1 AU 2003296869 A1 AU2003296869 A1 AU 2003296869A1 AU 2003296869 A AU2003296869 A AU 2003296869A AU 2003296869 A AU2003296869 A AU 2003296869A AU 2003296869 A1 AU2003296869 A1 AU 2003296869A1
Authority
AU
Australia
Prior art keywords
dendritic cells
inducing differentiation
novel molecule
molecule
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003296869A
Inventor
Ramasamy Vijaya Anand
Anil Chatterji
Ehrlich Desa
Venkatasamy Manivel
Krishnamurthy Natarajan
Kanury Venkata Subba Rao
Vinod Kumar Singh
Parameswaran Perunninakulath Subrayan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
Original Assignee
Council of Scientific and Industrial Research CSIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council of Scientific and Industrial Research CSIR filed Critical Council of Scientific and Industrial Research CSIR
Publication of AU2003296869A1 publication Critical patent/AU2003296869A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C305/00—Esters of sulfuric acids
    • C07C305/02—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C305/04—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton being acyclic and saturated
    • C07C305/06—Hydrogenosulfates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/02—Monoamides of sulfuric acids or esters thereof, e.g. sulfamic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/17—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing carboxyl groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/17—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing carboxyl groups bound to the carbon skeleton
    • C07C309/18—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing carboxyl groups bound to the carbon skeleton containing amino groups bound to the same carbon skeleton
AU2003296869A 2003-10-20 2003-12-31 Novel molecule for inducing differentiation of dendritic cells Abandoned AU2003296869A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51218303P 2003-10-20 2003-10-20
US60/512,183 2003-10-20
PCT/IN2003/000432 WO2005037775A1 (en) 2003-10-20 2003-12-31 Novel molecule for inducing differentiation of dendritic cells

Publications (1)

Publication Number Publication Date
AU2003296869A1 true AU2003296869A1 (en) 2005-05-05

Family

ID=34465322

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2003290418A Abandoned AU2003290418A1 (en) 2003-10-20 2003-12-31 Novel molecules to develop drug for the treatment of osteoporosis
AU2003290427A Abandoned AU2003290427A1 (en) 2003-10-20 2003-12-31 Novel molecule for inducing differentiation of dendritic cells
AU2003296869A Abandoned AU2003296869A1 (en) 2003-10-20 2003-12-31 Novel molecule for inducing differentiation of dendritic cells

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AU2003290418A Abandoned AU2003290418A1 (en) 2003-10-20 2003-12-31 Novel molecules to develop drug for the treatment of osteoporosis
AU2003290427A Abandoned AU2003290427A1 (en) 2003-10-20 2003-12-31 Novel molecule for inducing differentiation of dendritic cells

Country Status (5)

Country Link
US (3) US7335686B2 (en)
EP (3) EP1678125A1 (en)
JP (1) JP4587955B2 (en)
AU (3) AU2003290418A1 (en)
WO (3) WO2005037776A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2899895B1 (en) * 2006-04-12 2010-09-17 Servier Lab NOVEL STRONTIUM SALTS OF SULFONIC ACIDS, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2955326B1 (en) * 2010-01-18 2015-01-02 Sederma Sa NOVEL LIPO-PHOSPHATE OR LIPO-SULFATE COMPOUND, COMPOSITIONS CONTAINING SAME AND COSMETIC AND DERMOPHARMACEUTICAL USES
CN103980140A (en) * 2014-05-23 2014-08-13 福州大学 Abalone shell sourced calcium glutamate and preparation method thereof
CN111450244B (en) * 2020-04-30 2024-03-26 北京翊博普惠生物科技发展有限公司 Cell combination for preventing and treating coronavirus infection and application thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1770863A1 (en) * 1968-07-11 1972-01-13 Hoechst Ag Process for the production of modified polyamides
US4056491A (en) * 1974-08-05 1977-11-01 Ppg Industries, Inc. Detergent compositions of trisulfosuccinic acid
KR980009238A (en) * 1995-07-28 1998-04-30 우에노 도시오 Sulfonyl amino acid derivative
JPH10245588A (en) * 1997-03-04 1998-09-14 Nof Corp Detergent composition
JP3484161B2 (en) * 1997-09-18 2004-01-06 ピアース バイオテクノロジー，インク． Sulfo-N-hydroxysuccinimide and method for producing the same
US6124314A (en) 1997-10-10 2000-09-26 Pfizer Inc. Osteoporosis compounds
JP2000137345A (en) * 1998-10-30 2000-05-16 Ricoh Co Ltd Electrophotographic photoreceptor, method of maintenance of electrophotographic photoreceptor, and electrophotographic device
US6271200B1 (en) * 1998-12-21 2001-08-07 Generex Pharmaceuticals Inc. Proteinic drug delivery system using aerosolized membrane-mimetic amphiphiles
US6596303B1 (en) * 1999-03-22 2003-07-22 Mars Incorporated Pet food for maintenance of joint health and alleviation of arthritic symptoms in companion animals
JP2000341302A (en) 1999-05-27 2000-12-08 Sony Corp Electronic device
AU2001271926A1 (en) * 2000-07-13 2002-01-30 University Of Southern California Methods for promoting dendritic cell proliferation or differentiation
US6905710B2 (en) * 2001-08-31 2005-06-14 Council Of Scientific And Industrial Research Pharmaceutical composition useful for inhibition of osteoclast formation and a process for the extraction of mussel hudrolysate from indian green mussel
SE0201713D0 (en) * 2001-11-23 2002-06-06 Gramineer Internat Ab New methods and use III

Also Published As

Publication number Publication date
US20050085547A1 (en) 2005-04-21
WO2005037774A1 (en) 2005-04-28
JP2007534610A (en) 2007-11-29
AU2003290427A1 (en) 2005-05-05
EP1678124B1 (en) 2014-07-16
WO2005037776A1 (en) 2005-04-28
US20050085537A1 (en) 2005-04-21
JP4587955B2 (en) 2010-11-24
EP1678124A1 (en) 2006-07-12
US20050085546A1 (en) 2005-04-21
EP1678125A1 (en) 2006-07-12
EP1680396A1 (en) 2006-07-19
AU2003290418A1 (en) 2005-05-05
US7335686B2 (en) 2008-02-26
WO2005037775A1 (en) 2005-04-28

Similar Documents

Publication Publication Date Title
AU2003901099A0 (en) Methods of inducing differentiation of stem cells
AU2002318386A1 (en) Methods for characterization of nucleic acid molecules
AU2003263793A1 (en) Dendrimers as molecular translocators
AU2004266485A1 (en) Phenoxiacetic acid derivatives
AU2003236138A1 (en) Incubator for observation by microscope
AU2003288304A1 (en) Novel molecules derived from noraporphine
EP1585970A3 (en) Methods for separating molecules
AU2003286588A1 (en) Methods for synthesizing complementary dna
AU2003250506A1 (en) Method for the characterisation of nucleic acid molecules
AU2003902514A0 (en) Personal support aid
EP1536007A4 (en) Artificial mammalian chromosome
AU2003303648A1 (en) Novel 5-hydroxyindole-3-carboxylate derivatives
AU2003296869A1 (en) Novel molecule for inducing differentiation of dendritic cells
AU2003279121A1 (en) Process for controlling molecular weight of polymer
AU2003232036A1 (en) Nanoarchaeum nucleic acid molecule
AU2002257064A1 (en) Methods for isolating proteins expressed by dendritic cells
AU2003902363A0 (en) Cell separation
AU2004225794A8 (en) Process for the electrolysis of aluminiumsulfide
AU2003269486A1 (en) An improved process for the preparation of pure nisoldipine
AU2002368450A1 (en) Radioablation of hemolymphopoietic cell populations
AU2003270143A1 (en) Improved methods for the synthesis of nucleic acids
AU2003272080A1 (en) Novel process for the preparation of tert-butyl 6-cyano-5-hydroxy-3-oxohexanoate
AU2003263582A1 (en) Process for the manufacture of rofecoxib
AU2003238733A1 (en) All-climate artificial driving range for golf
AU2003269993A1 (en) Haplotype structures of chromosome 21

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase